drugset / Trial / NCT04743414

Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects

NCT04743414

Phase 1 Completed 22 enrolled Concert Pharmaceuticals
NaSequentialOpen-labelOther

Summary

This is a Phase 1 open-label study of the effect of itraconazole on the pharmacokinetics of CTP-543 in healthy subjects.

Timeline

Start
2021-03-02
Primary completion
2021-03-27
Completion
2021-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP-543 Unknown Oral
Subject Itraconazole Small molecule Oral

Indications

No indication recorded.